Belluscura (BELL), a medical device developer, said that three additional US patents have recently issued, increasing the number of issued and pending patent applications the company owns or exclusively licenses
Belluscura (BELL), a medical device developer, said that three additional US patents have recently issued, increasing the number of issued and pending patent applications the company owns or exclusively licenses
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Actual, Bens, Belluscura, Canadian,
Chaarat (CGH), the AIM-quoted gold mining company with an operating mine in Armenia, and assets at various stages of development in the Kyrgyz Republic, announced its audited full-year results for
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is Amur, Angus, Avacta, Belluscura, Empire, Galileo,
The positive newsflow keeps on coming for Open Orphan (ORPH), the specialist contract research organisation.
Although the news was widely distributed yesterday, presumably to give shareholders an extra bad night’s sleep,
Zak Mir takes a charting perspective to some of the most followed small-cap stocks on the London market. Today’s selection includes Atlantic Lithium, Beowulf, Belluscura, Catenae, Equals, Future, Ironveld, Novacyt,
Dev Clever (DEV), the developer of online and immersive career guidance and development platforms, provided a trading update for the financial year ended 31 October 2021.
Zak Mir takes a technical look at some of the most followed stocks on the London market. Today’s selection includes Abingdon, Belluscura, Challenger, Eve, Online, Powerhouse, Pantheon, Pires, Physiomics, Poolbeg,
Zak Mir takes a technical look at some of the most followed small caps on the London market. Today’s selection includes Avacta, Belluscura, Caerus, Castillo Copper, Eve Sleep, Valereum and
Diagnostics continue to surf the rollercoaster of the pandemic / post-pandemic period, something which has been underlined by the latest update from Omega Diagnostics (ODX) on the occasion of the